GlassScriptPhysician profile
Anthony Carroccia
NPI 1609876572
$9,177.81
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,576 · 2020: $72.93 · 2021: $3,062 · 2022: $184 · 2023: $224 · 2024: $58.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $189 · Food and Beverage: $58.13 · Consulting Fee: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $189.46 |
| Food and Beverage | $58.13 |
| Consulting Fee | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $3,447.95 | 2019-2022 | |
| Hu-Friedy Mfg. Co., LLC | $3,000.00 | 2021 | |
| Strategic Dentistry LLC | $2,107.00 | 2019 | |
| Scican INC | $202.20 | 2019 | |
| Kerr Corporation | $189.46 | 2023 | Simplishade |
| Septodont INC. | $72.93 | 2020 | |
| Zimvie INC. | $58.13 | 2024 | |
| Align Technology, INC. | $35.00 | 2023 | Itero, Invisalign |
| Zimmer Biomet Holdings, INC. | $34.88 | 2019 | |
| Henry Schein, INC. | $30.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Carroccia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.